Deriving hepatocyte-like cells from placental cells for transplantation.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current Stem Cell Research & Therapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1574888X11308010004PMID 23270630
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue specific synthetic ECM hydrogels for 3-D in vitro maintenance of hepatocyte function.

  2012cited by this paper
• In vivo hepatic differentiation of mesenchymal stem cells from human umbilical cord blood after transplantation into mice with liver injury.

  2012cited by this paper
• Human Amniotic Epithelial Cell Transplantation Induces Markers of Alternative Macrophage Activation and Reduces Established Hepatic Fibrosis

  2012cited by this paper
• Hepatic differentiation of amniotic epithelial cells

  2011cited by this paper
• The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

  2011cited by this paper
• Human chorionic-plate-derived mesenchymal stem cells and Wharton’s jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells

  2011cited by this paper
• Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes

  2011cited by this paper
• Humanized mice with ectopic artificial liver tissues

  2011cited by this paper
• Transplanted Human Amniotic Membrane-Derived Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in Mouse

  2011cited by this paper
• Changes in Culture Expanded Human Amniotic Epithelial Cells: Implications for Potential Therapeutic Applications

  2011cited by this paper
• Primary human hepatocytes on biodegradable poly(l‐lactic acid) matrices: A promising model for improving transplantation efficiency with tissue engineering

  2011cited by this paper
• Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis?

  2011cited by this paper
• In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells

  2011cited by this paper
• Modulation of cytochrome P450 gene expression in primary hepatocytes on various artificial extracellular matrices.

  2011cited by this paper
• Human amniotic fluid-derived stem cells can differentiate into hepatocyte-like cells in vitro and in vivo

  2011cited by this paper
• Transplantation of microencapsulated umbilical-cord-blood-derived hepatic-like cells for treatment of hepatic failure.

  2011cited by this paper
• Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure

  2011cited by this paper
• Cytokine expression in placenta-derived mesenchymal stem cells in patients with pre-eclampsia and normal pregnancies.

  2010cited by this paper
• Multilineage differentiation potential of cells isolated from the human amniotic membrane

  2010cited by this paper
• Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair.

  2010cited by this paper
• The Expression of CD68 in Human Umbilical Cord Mesenchymal Stem Cells: New Evidences of Presence in Non‐Myeloid Cell Types

  2009cited by this paper
• Hepatocyte transplantation-induced liver inflammation is driven by cytokines-chemokines associated with neutrophils and Kupffer cells.

  2009cited by this paper
• Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells.

  2009cited by this paper
• The role of HGF on invasive properties and repopulation potential of human fetal hepatic progenitor cells.

  2009cited by this paper
• Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice.

  2009cited by this paper
• Encapsulation of Mesenchymal Stem Cells from Wharton's Jelly in Alginate Microbeads

  2009cited by this paper
• Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers

  2009cited by this paper
• Cell Phenotypes in Human Amniotic Fluid

  2009cited by this paper
• The Immunosuppressive Properties of Mesenchymal Stem Cells

  2009cited by this paper
• The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis

  2009cited by this paper
• Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells.

  2009cited by this paper
• Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells.

  2008cited by this paper
• Comparative Characterization of Cultured Human Term Amnion Epithelial and Mesenchymal Stromal Cells for Application in Cell Therapy

  2008cited by this paper
• Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.

  2008cited by this paper
• Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro.

  2008cited by this paper
• Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies.

  2008cited by this paper
• Dissimilar Differentiation of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, and Adipose Tissue

  2008cited by this paper
• Characterization and hepatogenic differentiation of mesenchymal stem cells from human amniotic fluid and human bone marrow: A comparative study

  2008cited by this paper
• Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy.

  2008cited by this paper
• Isolation of amniotic stem cell lines with potential for therapy

  2007cited by this paper
• Molecular and Proteomic Characterization of Human Mesenchymal Stem Cells Derived from Amniotic Fluid: Comparison to Bone Marrow Mesenchymal Stem Cells

  2007cited by this paper
• Immunosuppressive Effects of Mesenchymal Stem Cells: Involvement of HLA-G

  2007cited by this paper
• Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro

  2007cited by this paper
• Dose-Dependent Immunomodulatory Effect of Human Stem Cells from Amniotic Membrane: A Comparison with Human Mesenchymal Stem Cells from Adipose Tissue

  2007cited by this paper
• Isolation and characterization of mesenchymal cells from human fetal membranes

  2007cited by this paper
• Stem Cells Derived from Human Fetal Membranes Display Multilineage Differentiation Potential

  2007cited by this paper
• Differentiating characterization of human umbilical cord blood‐derived mesenchymal stem cells in vitro

  2006cited by this paper
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

  2006cited by this paper
• In Vitro Differentiation of Human Placenta‐Derived Multipotent Cells into Hepatocyte‐Like Cells

  2006cited by this paper
• Alginate‐PLL microencapsulation: Effect on the differentiation of embryonic stem cells into hepatocytes

  2006cited by this paper
• Alginate-based microcapsules for immunoisolation of pancreatic islets.

  2006cited by this paper
• Cell competition leads to a high level of normal liver reconstitution by transplanted fetal liver stem/progenitor cells.

  2006cited by this paper
• Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes.

  2005cited by this paper
• Stem Cell Characteristics of Amniotic Epithelial Cells

  2005cited by this paper
• Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration.

  2005cited by this paper
• Human umbilical cord blood-derived cells differentiate into hepatocyte-like cells in the Fas-mediated liver injury model.

  2005cited by this paper
• In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells.

  2005cited by this paper
• Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity

  2005cited by this paper
• Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose Tissue

  2004cited by this paper
• Fibroblast growth factor enriches the embryonic liver cultures for hepatic progenitors.

  2004cited by this paper
• Human amniotic epithelial cells possess hepatocyte-like characteristics and functions.

  2004cited by this paper
• Engraftment Potential of Human Amnion and Chorion Cells Derived from Term Placenta

  2004cited by this paper
• Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol.

  2004cited by this paper
• Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder.

  2003cited by this paper
• Human Umbilical Cord Blood as a Source of Transplantable Hepatic Progenitor Cells

  2003cited by this paper
• Human Amnion-Isolated Cells Normalize Blood Glucose in Streptozotocin-Induced Diabetic Mice

  2003cited by this paper
• HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures.

  2003cited by this paper
• Microencapsulated multicellular spheroid of rat hepatocytes transplanted intraperitoneally after 90% hepatectomy.

  2002cited by this paper
• Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm.

  2001cited by this paper
• Hepatocyte transplantation in acute liver failure

  2000cited by this paper
• Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer

  1999cited by this paper
• Hepatocyte transplantation for the treatment of human disease.

  1999cited by this paper
• GATA transcription factors as potentiators of gut endoderm differentiation.

  1998cited by this paper
• Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice.

  1991cited by this paper
• Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep.

  1989cited by this paper

• In Vitro and In Vivo Hepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases

  2015influential citation
• Hepatocyte cell therapy in liver disease

  2015cites this paper
• How far are we from the clinical use of placental-derived mesenchymal stem cells?

  2015cites this paper
• Placenta-Derived Cells and Their Therapeutic Applications

  2014cites this paper
• Hepatocyte-Like Cells Derived from Human Amniotic Epithelial Cells Can Be Encapsulated Without Loss of Viability or Function In Vitro

  2014cites this paper
• Human Skin-Derived Stem Cells as a Novel Cell Source for In Vitro Hepatotoxicity Screening of Pharmaceuticals

  2014cites this paper
• Treatment of Liver Disease Using Placental Stem Cells: Feasibility of Placental Stem Cells in Liver Diseases: Potential Implication of New Cell Therapy-Based Strategies for Hepatic Diseases

  2014cites this paper
• Perinatal stem cells revisited: directions and indications at the crossroads between tissue regeneration and repair.

  2013cites this paper